Nuventra Pharma Sciences:

We are a clinical pharmacology consulting
firm specializing in pharmacokinetics (PK),
pharmacodynamics (PD), PK/PD,
and pharmacometrics (popPK)

Pharmacokinetic Experts:

Our "Less Is More" philosophy leads to
a focused business model to provide
excellence in PK/PD and clinical pharmacology

Focused on PK/PD:

Our focus on PK/PD and clinical pharmacology
translates into broad & extensive experience in this field.

The Nuventra Advantage:

We take complex pharmacokinetic principles and make
them understandable and usable for common sense
drug development.

Therapeutic Areas:

We've worked in many
different therapeutic areas...


A Smarter Way to do PK/PD

Nuventra Pharma Sciences

Nuventra was founded in 2008 under the name ClinPharm Consulting and was organized under a “less is more” philosophy to provide excellence solely in the fields of clinical pharmacology, pharmacokinetics, pharmacometrics, and phase 1 studies. As such, the range of our experience in these fields is broad and extensive, which translates into the better advice and services for our clients.


A common sense approach based on scientific principles to provide excellence in pharmacokinetics.
Learn More


Automated toxicokinetic report generation using a proprietary programming code. Learn More

'Darwin' Genetic Algorithm for PopPK

Automated PopPK model selection via computer algorithm...named 'Darwin for NONMEM'...saves time and money.
Learn More

Virtual PK Group

Senior level consultants provide expert services to companies lacking pharmacokinetic and clinical pharmacology expertise in-house.
Learn More

Nuventra is the pharmaceutical industry’s go-to resource for PK/PD analysis and provides pharmaceutical companies and CROs rare access to a hands-on team of industry-leading consultants experienced in complex studies and analyses across multiple therapeutic areas. We embrace the notion that simplicity and clarity lead to good decisions by taking complex pharmacokinetic, pharmacodynamic, and pharmacometric (popPK) principals and making them understandable and usable for common sense drug development. Nuventra’s flexible business structure enables our expert consultants to integrate within our clients’ R&D group and help them maximize the potential of their clinical pharmacology/Phase 1 study and PK/PD analysis to pave the way toward marketing approval.

Clinical Pharmacology Plan

Hear about our "Clinical Pharmacology Plan" for an overall drug development program.

Conducting a Typical PK Analysis

Learn about our process for conducting pharmacokinetic analyses.

Nuventra Delivers Clinical Pharmacology & PK Consulting Services

Hear how Nuventra is changing the paradigm for delivering expertise in pharmacokinetics.

What Makes Nuventra Different

Dr. Geoffrey Banks, Nuventra's CEO discusses what makes our company different.

The Nuventra Advantage

  • Our Consultants

    Our consultants don't just give you PK and PD data, we are adept at presenting complex pharmacokinetic data in a manner that is usable for rational drug development.
  • Our Experience

    Our expert senior consultants have 15 to 30 years of experience in clinical pharmacology, TK, DMPK, PK, PD, PK/PD and pharmacometrics
  • Our Focus

    With our focus in drug development, Nuventra's consultants see a tremendous diversity of compounds, development programs, and complex analyses. These experiences allow Nuventra to be the best partner for companies developing small molecule therapeutics and biologics
  • Your Partner

    We integrate into our client's R&D group and become an extension of their operation. This allows us to be a true partner in drug development beyond just a simple client-vendor relationship.
  • Strategic Advice

    Rather than evaluate an individual study or analysis in a silo, Nuventra's consultants take a horizontal approach to providing strategic advice across an entire development program. We help interpret and apply PK data from clinical and nonclinical studies to next steps in a development program.
  • Phase 1 Studies

    Nuventra uses scientific principals to design, conduct, analyze and report clinical pharmacology Phase 1 studies.